Pablo Machado

2.9k total citations · 1 hit paper
112 papers, 2.3k citations indexed

About

Pablo Machado is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Pablo Machado has authored 112 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 44 papers in Organic Chemistry and 37 papers in Infectious Diseases. Recurrent topics in Pablo Machado's work include Tuberculosis Research and Epidemiology (31 papers), Synthesis and biological activity (22 papers) and Biochemical and Molecular Research (15 papers). Pablo Machado is often cited by papers focused on Tuberculosis Research and Epidemiology (31 papers), Synthesis and biological activity (22 papers) and Biochemical and Molecular Research (15 papers). Pablo Machado collaborates with scholars based in Brazil, United States and Uruguay. Pablo Machado's co-authors include Marcos A. P. Martins, Dayse N. Moreira, Clarissa P. Frizzo, Lilian Buriol, Hélio G. Bonacorso, Nilo Zanatta, Luiz Augusto Basso, Cristiano Valim Bizarro, Juliano Ferreira and Maribel Antonello Rubin and has published in prestigious journals such as Chemical Reviews, Nature Communications and Bioinformatics.

In The Last Decade

Pablo Machado

107 papers receiving 2.2k citations

Hit Papers

Solvent-Free Heterocyclic Synthesis 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Solvent-Free Heterocyclic Synthesis
    2009 549 citations Marcos A. P. Martins, Pablo Machado et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Machado Brazil 25 1.3k 607 249 227 210 112 2.3k
Evans C. Coutinho India 24 1.1k 0.9× 1.2k 2.0× 260 1.0× 256 1.1× 113 0.5× 156 2.9k
Andrea Pinto Italy 28 1.0k 0.8× 1.5k 2.5× 82 0.3× 195 0.9× 193 0.9× 144 2.8k
Venkatesan Jayaprakash India 30 1.1k 0.8× 748 1.2× 240 1.0× 456 2.0× 96 0.5× 122 2.3k
Stanton F. McHardy United States 20 556 0.4× 571 0.9× 263 1.1× 206 0.9× 207 1.0× 53 1.5k
Rosanna Filosa Italy 30 732 0.6× 796 1.3× 96 0.4× 272 1.2× 126 0.6× 83 2.4k
Ricardo José Nunes Brazil 30 1.1k 0.8× 867 1.4× 129 0.5× 267 1.2× 121 0.6× 107 2.4k
Maria do Carmo Alves de Lima Brazil 30 1.3k 1.0× 922 1.5× 84 0.3× 250 1.1× 182 0.9× 178 2.7k
Mariangela Biava Italy 32 1.3k 1.0× 928 1.5× 738 3.0× 371 1.6× 478 2.3× 102 2.6k
Ross P. McGeary Australia 29 632 0.5× 1.0k 1.7× 234 0.9× 247 1.1× 261 1.2× 101 2.3k
Mange Ram Yadav India 30 1.5k 1.1× 938 1.5× 196 0.8× 481 2.1× 77 0.4× 167 2.7k

Countries citing papers authored by Pablo Machado

Since Specialization
Citations

This map shows the geographic impact of Pablo Machado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Machado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Machado more than expected).

Fields of papers citing papers by Pablo Machado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Machado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Machado. The network helps show where Pablo Machado may publish in the future.

Co-authorship network of co-authors of Pablo Machado

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Machado. A scholar is included among the top collaborators of Pablo Machado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Machado. Pablo Machado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sousa, Natália Ferreira de, Helivaldo Diógenes da Silva Souza, Luciana Scotti, et al.. (2025). Preclinical Evaluation of Selene-Ethylenelacticamides in Tuberculosis: Effects Against Active, Dormant, and Resistant Mycobacterium Tuberculosis and In Vitro Toxicity Investigation. Microorganisms. 13(2). 396–396. 1 indexed citations
2.
Cristiano, Rodrigo, Cristiano Valim Bizarro, Pablo Machado, et al.. (2025). In Vitro and In Silico Evaluation of Isatin‐Derived Spirooxindoles as Antituberculosis Drug Candidates. Chemical Biology & Drug Design. 106(1). e70152–e70152.
3.
Bookout, Angie L., Christopher A. Barnes, Brendan Miller, et al.. (2024). Rp3: Ribosome profiling-assisted proteogenomics improves coverage and confidence during microprotein discovery. Nature Communications. 15(1). 6839–6839. 7 indexed citations
4.
Rambo, Raoní Scheibler, Carlos Alexandre Sanchez Ferreira, Sı́lvia Dias de Oliveira, et al.. (2024). Unveiling the Antimycobacterial Potential of Novel 4-Alkoxyquinolines: Insights into Selectivity, Mechanism of Action, and In Vivo Exposure. Journal of Medicinal Chemistry. 67(24). 21781–21794. 2 indexed citations
5.
Antunes, Krist Helen, Cristiano Valim Bizarro, Luiz Augusto Basso, et al.. (2023). SARS-CoV-2 immune complex triggers human monocyte necroptosis. International Immunopharmacology. 117. 109954–109954. 3 indexed citations
6.
Saghatelian, Alan, et al.. (2022). µProteInS—a proteogenomics pipeline for finding novel bacterial microproteins encoded by small ORFs. Bioinformatics. 38(9). 2612–2614. 7 indexed citations
7.
Abbadi, Bruno Lopes, et al.. (2022). Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments. Journal of Computer-Aided Molecular Design. 37(3). 117–128. 4 indexed citations
8.
Gularte, Juliana Schons, Meriane Demoliner, Alana Witt Hansen, et al.. (2022). Viral isolation allows characterization of early samples of SARS-CoV-2 lineage B1.1.33 with unique mutations (S: H655Y and T63N) circulating in Southern Brazil in 2020. Brazilian Journal of Microbiology. 53(3). 1313–1319. 2 indexed citations
9.
Abbadi, Bruno Lopes, Nathalia Sperotto, Letícia Beatriz Matter, et al.. (2022). Evaluation of 3-Deoxy-D-Arabino-Heptulosonate 7-Phosphate Synthase (DAHPS) as a Vulnerable Target in Mycobacterium tuberculosis. Microbiology Spectrum. 10(4). e0072822–e0072822. 2 indexed citations
10.
Ducati, Rodrigo G., Kenia Pissinate, Raoní Scheibler Rambo, et al.. (2021). 8-Mercaptoguanine-based inhibitors of Mycobacterium tuberculosis dihydroneopterin aldolase: synthesis, in vitro inhibition and docking studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 847–855. 1 indexed citations
11.
Timmers, Luís Fernando Saraiva Macedo, et al.. (2020). Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs. Molecules. 25(6). 1259–1259. 41 indexed citations
12.
Antunes, Géssica Luana, Krist Helen Antunes, Carine Raquel Richter Schmitz, et al.. (2020). Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo. European Journal of Pharmacology. 890. 173670–173670. 11 indexed citations
13.
Salbego, Paulo R. S., Thiago V. Acunha, Bruno Lopes Abbadi, et al.. (2019). Synthesis and photophysical, thermal and antimycobacterial properties of novel 6-amino-2-alkyl(aryl/heteroaryl)-4-(trifluoromethyl) quinolines. New Journal of Chemistry. 43(31). 12375–12384. 17 indexed citations
14.
Rodrigues, Rafael C., et al.. (2019). Cloning and expression of the Bacillus amyloliquefaciens transglutaminase gene in E. coli using a bicistronic vector construction. Enzyme and Microbial Technology. 134. 109468–109468. 18 indexed citations
15.
Rodrigues-Junior, Valnês S., Anne Drumond Villela, Bruno Lopes Abbadi, et al.. (2019). Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy. Regulatory Toxicology and Pharmacology. 111. 104553–104553. 13 indexed citations
16.
Villela, Anne Drumond, Valnês S. Rodrigues-Junior, Leonardo Martinelli, et al.. (2017). Synthesis, Inhibition of Mycobacterium tuberculosis Enoyl-acyl Carrier Protein Reductase and Antimycobacterial Activity of Novel Pentacyanoferrate(II)-isonicotinoylhydrazones. Journal of the Brazilian Chemical Society. 6 indexed citations
17.
Subtil, Fernanda Teixeira, Anne Drumond Villela, Bruno Lopes Abbadi, et al.. (2017). Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing. International Journal of Antimicrobial Agents. 51(3). 378–384. 19 indexed citations
18.
Tonello, Raquel, Jardel Gomes Villarinho, Pablo Machado, et al.. (2011). The potential antidepressant-like effect of imidazoline I2 ligand 2-BFI in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 37(1). 15–21. 16 indexed citations
19.
Sauzem, P.D., Pablo Machado, Marta Maria Medeiros Frescura Duarte, et al.. (2009). Effect of 5-trifluoromethyl-4,5-dihydro-1H-pyrazoles on chronic inflammatory pain model in rats. European Journal of Pharmacology. 616(1-3). 91–100. 42 indexed citations
20.
Rossato, Mateus, Sara Marchesan Oliveira, Carine Cristiane Drewes, et al.. (2008). Antinociceptive action of 4-methyl-5-trifluoromethyl-5-hydroxy-4, 5-dihydro-1H-pyrazole methyl ester in models of inflammatory pain in mice. Life Sciences. 83(21-22). 739–746. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evans C. Coutinho Breakdown of academic impact, for papers by Andrea Pinto Breakdown of academic impact, for papers by Venkatesan Jayaprakash Breakdown of academic impact, for papers by Stanton F. McHardy Breakdown of academic impact, for papers by Rosanna Filosa Breakdown of academic impact, for papers by Ricardo José Nunes Breakdown of academic impact, for papers by Maria do Carmo Alves de Lima Breakdown of academic impact, for papers by Mariangela Biava Breakdown of academic impact, for papers by Ross P. McGeary Breakdown of academic impact, for papers by Mange Ram Yadav
Rankless by CCL
2026